biomarkers

Videos

Real-World Biomarker Testing, Treatment Patterns in CLL/SLL

12/17/2020

Anthony Mato, MD, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with CLL in the clinical practice setting, using the informCLL prospective registry.

Anthony Mato, MD, discusses...

12/17/2020

Journal of Clinical Pathways

Research Reports

KRAS/RAS Testing Is Associated With Reduced Risk of Treatment Discontinuation in Patients With Metastatic Colorectal Cancer

08/22/2018

Andrew J. Klink , PhD, MPH;

Bruce A. Bach , MD, PhD;

Urvi Mujumdar , MPH;

Bruce A. Feinberg , DO;

Alexandra Christodoulopoulou , MSc;

Marwan Fakih , MD;

Guy Hechmati , MD, MSc;

Abstract: Current clinical guidelines recommend that all patients with metastatic colorectal cancer (mCRC) have tumor tissue genotyped for RAS mutations. This study aimed to evaluate patient characteristics and...

...

08/22/2018

Journal of Clinical Pathways

Quiz

A Flawed Biomarker for Bladder Cancer?

11/03/2016

JCP Editors

While previously reported as a promising biomarker for bladder cancer, a recent study published in Cancer found that which of the following was not a reliable predictor of cancer progression or treatment...

...

11/03/2016

Journal of Clinical Pathways

Potential Biomarkers for Bladder Cancer Identified

10/27/2016

JCP Editors

Tumor cells collected during the removal of a cancerous bladder may help clinicians better identify high-risk cancers, determine prognosis, refine their use of biomarkers, and provide more personalized care,...

Tumor...

10/27/2016

Journal of Clinical Pathways

Research in Review

MicroRNA a Novel Biomarker for Gastric Cancer

10/12/2016

JCP Editors

Serum microRNA-206 (miRNA) may serve as not only a novel diagnostic biomarker for gastric cancer but also as an indicator of prognosis and cancer recurrence, according to a study published in Cellular Physiology and...

Serum...

10/12/2016

Journal of Clinical Pathways

Department

Keynote Presentation - Precision Medicine: An Essential Component of Oncology Clinical Pathways

09/17/2016

JCP Editors

Richard Schilsky, MD, senior vice president and chief medical officer of the American Society of Clinical Oncology kicked off the inaugural Clinical Pathways Congress with a discussion on the relationship between...

...

09/17/2016

Journal of Clinical Pathways

Research in Review

Gene Assay May Predict Treatment Response in Lung Cancer

09/09/2016

JCP Editors

In a new study, researchers identified 14 centromere and kinetochore (CEN/KT) genes regulating genome integrity that were consistently overexpressed in a variety of cancers. This allowed the researchers to create the...

In a...

09/09/2016

Journal of Clinical Pathways

Research in Review

Immune Signatures Predict Treatment Response for Melanoma

09/01/2016

JCP Editors

Adaptive immune signatures in tumor biopsy samples obtained early during the course of treatment may be used to predict patient response to melanoma immunotherapy, according to a study published in Cancer...

...

09/01/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz ‚Äì August 21-28

08/25/2016

JCP Editors

A study published in Science Translational Medicine found that the inhabitation of what oncogenic protein might possibly be a target for therapeutic benefit in patients with non-small cell lung...

A...

08/25/2016

Journal of Clinical Pathways

Research in Review

New Lung Cancer Biomarker Identified

08/22/2016

JCP Editors

Inhibition of oncogenic protein BMI1 may offer a therapeutic benefit for certain patients with lung cancer, according to the results of an analysis published in Science Translational Medicine. In a prior study,...

...

08/22/2016

Journal of Clinical Pathways